[1]
“Soluble ST2 and its relation to inflammatory, vascular atherosclerotic, and calcification markers in patients with atrial fibrillation or heart failure at moderate-to-high cardiovascular risk”, Eastern J Med Sci, vol. 7, no. 2, pp. 37–43, Feb. 2024, doi: 10.32677/ejms.v7i2.3492.